ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,312,863 | -33.0% | 73,140 | -24.2% | 0.00% | -33.3% |
Q2 2023 | $1,959,224 | +1180.5% | 96,466 | +1553.8% | 0.01% | – |
Q3 2022 | $153,000 | -67.2% | 5,833 | -68.4% | 0.00% | -100.0% |
Q2 2022 | $467,000 | +5737.5% | 18,435 | +7985.5% | 0.00% | – |
Q3 2021 | $8,000 | -74.2% | 228 | -79.4% | 0.00% | – |
Q1 2021 | $31,000 | +342.9% | 1,108 | +321.3% | 0.00% | – |
Q4 2020 | $7,000 | – | 263 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |